Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients

Liver Transplantation

Volumn 20, Issue 6, 2014, Pages 679-686

  Venkat, Veena L ^a   Ranganathan, Sarangarajan ^a   Mazariegos, George V ^b   Sun, Qing ^b   Sindhi, Rakesh ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AZATHIOPRINE; GANCICLOVIR; LEUKOCYTE ANTIGEN; MERCAPTOPURINE; MESALAZINE; MYCOPHENOLIC ACID; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; URSODEOXYCHOLIC ACID; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY;

ABDOMINAL PAIN; ARTERY OCCLUSION; ARTICLE; CHILD; CLINICAL ARTICLE; COLITIS; CYTOMEGALOVIRUS; DISEASE MARKER; EPSTEIN BARR VIRUS; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATIC ARTERY; HISTOPATHOLOGY; HISTORY; HUMAN; ILEITIS; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; JAUNDICE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM CARE; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; NAUSEA; OBSERVATION; PATHOGENESIS; PRESCHOOL CHILD; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETRANSPLANTATION; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; STENOSIS; ULCERATIVE COLITIS; VIREMIA; VOMITING; ADOLESCENT; AGE; BIOPSY; CASE REPORT; CHOLANGITIS, SCLEROSING; FATALITY; IMMUNOLOGY; MORTALITY; TIME; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; AGE FACTORS; ANTILYMPHOCYTE SERUM; BIOPSY; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; FATAL OUTCOME; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; PENNSYLVANIA; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STEROIDS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901452532     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23868     Document Type: Article

References (22)

1. Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS,. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 2007; 102: 1042-1049.
2. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364-1369.
3. Broomé U, Olsson R, Lööf L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610-615.
4. Batres LA, Russo P, Mathews M, Piccoli DA, Chuang E, Ruchelli E,. Primary sclerosing cholangitis in children: a histologic follow-up study. Pediatr Dev Pathol 2005; 8: 568-576.
5. Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P,. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003; 38: 210-217.
6. Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N,. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol 2009; 7: 239-245.
7. Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St Louis P, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995; 22: 1415-1422.
8. Debray D, Pariente D, Urvoas E, Hadchouel M, Bernard O,. Sclerosing cholangitis in children. J Pediatr 1994; 124: 49-56.
9. Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E,; for Studies of Pediatric Liver Transplantation Research Group. Pediatric liver transplantation for primary sclerosing cholangitis. Liver Transpl 2011; 17: 925-933.
10. Graziadei IW,. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2002; 8: 575-581.
11. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 2000; 31: 792-799.
12. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-663.
13. Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D, Neuberger J,. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 2009; 15: 330-340.
14. Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV,. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2008; 14: 245-251.
15. Brandsaeter B, Schrumpf E, Bentdal O, Brabrand K, Smith HJ, Abildgaard A, et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 2005; 11: 1361-1369.
16. Cholongitas E, Shusang V, Papatheodoridis GV, Marelli L, Manousou P, Rolando N, et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2008; 14: 138-143.
17. Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003; 9: 727-732.
18. Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, et al. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum Pathol 2003; 34: 1127-1136.
19. Egawa H, Ueda Y, Ichida T, Teramukai S, Nakanuma Y, Onishi S, Tsubouchi H,. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry. Am J Transplant 2011; 11: 518-527.
20. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kam I,. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course. Liver Transpl 2008; 14: 181-185.
21. Talukdar A, AshokKumar C, Farrar J, Wilson P, Janakiramanan A, Tregaskes M, Sindhi R,. Lymphocyte subset reconstitution in pediatric liver recipients induced with steroid-free rabbit anti-human thymocyte globulin. Pediatr Transplant 2008; 12: 804-808.
22. Mieli-Vergani G, Vergani D,. Paediatric autoimmune liver disease. Arch Dis Child 2013; 98: 1012-1017.